Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Sue Yom, MD, PhD

    TitleAssociate Professor
    SchoolUCSF School of Medicine
    DepartmentRadiation Oncology
    Address1600 Divisadero
    San Francisco CA 94115
    Phone415-353-7410
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of PennsylvaniaM.D.School of Medicine2002

      Collapse Overview 
      Collapse Overview
      I am a radiation oncologist who specializes in the treatment of head and neck, skin and thoracic cancers.

      Major research interests include:

      - clinical management of head and neck, lung, and skin cancers
      - technical innovations in radiation therapy
      - novel combinations of targeted therapy and immunotherapy with radiation
      - virally driven cancers such as humanpapillomavirus, Epstein-Barr virus, and Merkel cell polyomavirus
      - biomarkers for radiation responsiveness or resistance
      - radioprotectants
      - preclinical development of radiation sensitizers
      - patient-centered decision making
      - outcomes research in the context of high-value care


      Collapse ORNG Applications 
      Collapse Websites
      Collapse Clinical Trials

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Chan JW, Parvathaneni U, Yom SS. Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma. Future Oncol. 2016 Nov 23. PMID: 27875901.
        View in: PubMed
      2. Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee V, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Future Oncol. 2016 Nov 15. PMID: 27842456.
        View in: PubMed
      3. Zevallos JP, Yom SS. Redefining the Role of Surgical Management in the Evolving Landscape of Oropharyngeal Cancer. J Oncol Pract. 2016 Nov; 12(11):1185-1187. PMID: 27858535.
        View in: PubMed
      4. Yu Y, Mabray M, Silveira W, Shen PY, Ryan WR, Uzelac A, Yom SS. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma. Head Neck. 2016 Oct 11. PMID: 27726241.
        View in: PubMed
      5. Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head Neck. 2016 Sep; 38(9):1299-309. PMID: 27330003.
        View in: PubMed
      6. Tan DS, Yom SS, Tsao MS, Pass HI, Kelly K, Peled N, Yung RC, Wistuba II, Yatabe Y, Unger M, Mack PC, Wynes MW, Mitsudomi T, Weder W, Yankelevitz D, Herbst RS, Gandara DR, Carbone DP, Bunn PA, Mok TS, Hirsch FR. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016. J Thorac Oncol. 2016 Jul; 11(7):946-63. PMID: 27229180.
        View in: PubMed
      7. Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom SS. ACR Appropriateness criteria® for nasopharyngeal carcinoma. Head Neck. 2016 Jul; 38(7):979-86. PMID: 27131050.
        View in: PubMed
      8. Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom SS. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy. J Med Imaging Radiat Oncol. 2016 Aug; 60(4):560-7. PMID: 27020481.
        View in: PubMed
      9. Singer L, Calkins SM, E Horvai A, R Ryan W, Yom SS. Xanthogranuloma in the heavily irradiated low neck in a patient with head and neck cancer. J Otolaryngol Head Neck Surg. 2016; 45(1):20. PMID: 27009318.
        View in: PubMed
      10. Anwar M, Yu Y, Glastonbury CM, El-Sayed IH, Yom SS. Delineation of radiation therapy target volumes for cutaneous malignancies involving the ophthalmic nerve (cranial nerve V-1) pathway. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e277-e281. PMID: 27687189.
        View in: PubMed
      11. Wyatt G, Pugh SL, Wong RK, Sagar S, Singh AK, Koyfman SA, Nguyen-Tân PF, Yom SS, Cardinale FS, Sultanem K, Hodson I, Krempl GA, Lukaszczyk B, Yeh AM, Berk L. Xerostomia health-related quality of life: NRG oncology RTOG 0537. Qual Life Res. 2016 Sep; 25(9):2323-33. PMID: 26914104.
        View in: PubMed
      12. Koyfman SA, Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS. ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Head Neck. 2016 Feb; 38(2):175-82. PMID: 26791005.
        View in: PubMed
      13. Chapman CH, Saba NF, Yom SS. Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation? Ann Transl Med. 2016 Feb; 4(4):80. PMID: 27004227.
        View in: PubMed
      14. Corry J, Yom SS. The Multidisciplinary Approach Needs to Extend Into Head and Neck Cancer Clinical Trials. Int J Radiat Oncol Biol Phys. 2016 Feb 1; 94(2):217-20. PMID: 26853330.
        View in: PubMed
      15. Yom SS. The softer (and furrier) side of oncology. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):285-6. PMID: 27025162.
        View in: PubMed
      16. Yu Y, Chen J, Leary CI, Shugard E, Yom SS. Split-field vs extended-field intensity-modulated radiation therapy plans for oropharyngeal cancer: Which spares the larynx? Which spares the thyroid? Med Dosim. 2016; 41(2):148-53. PMID: 26947055.
        View in: PubMed
      17. Yom SS, Ganti AK, Dietz A. What's New in Head and Neck Cancer: Key Findings in 2015-2016 From ECCO/ESMO, ASTRO, and the Multidisciplinary Head and Neck Cancer Symposium. Am Soc Clin Oncol Educ Book. 2016; 35:176-83. PMID: 27249698.
        View in: PubMed
      18. Fakhry C, Yom S, Gillison ML. Elective versus Therapeutic Neck Dissection in Oral Cancer. N Engl J Med. 2015 Dec 17; 373(25):2476. PMID: 26672855.
        View in: PubMed
      19. Yom SS. HPV and oropharyngeal cancer: etiology and prognostic importance. Semin Cutan Med Surg. 2015 Dec; 34(4):178-81. PMID: 26650695.
        View in: PubMed
      20. Yom SS, Gillison ML, Trotti AM. Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder. Int J Radiat Oncol Biol Phys. 2015 Dec 1; 93(5):986-8. PMID: 26581136.
        View in: PubMed
      21. Yom SS. Radiation treatment of head and neck cancer. Surg Oncol Clin N Am. 2015 Jul; 24(3):423-36. PMID: 25979392.
        View in: PubMed
      22. Raleigh DR, Algazi A, Arron ST, Neuhaus IM, Yom SS. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma. Br J Dermatol. 2015 Aug; 173(2):544-6. PMID: 25702621.
        View in: PubMed
      23. Singer L, Yom SS. Consolidative radiation therapy for extensive-stage small cell lung cancer. Transl Lung Cancer Res. 2015 Jun; 4(3):211-4. PMID: 26207205; PMCID: PMC4483471.
      24. Heaton CM, Al-Shwaiheen F, Liu CS, Yom SS, Ryan WR. Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation. Clin Otolaryngol. 2015 Jun; 40(3):260-5. PMID: 25641627.
        View in: PubMed
      25. Hemmat SM, Wang SJ, Uzelac A, Yom SS, Ryan WR. The Limitations of Routine Magnetic Resonance Imaging for Long-Term Post-Treatment Locoregional Surveillance of Salivary Carcinoma. ORL J Otorhinolaryngol Relat Spec. 2015; 77(3):132-40. PMID: 26022374.
        View in: PubMed
      26. Wong RK, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, Nguyen-Tân PF, Yom SS, Cardinale J, Yao M, Hodson I, Matthiesen CL, Suh J, Thakrar H, Pugh SL, Berk L. Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study. Int J Radiat Oncol Biol Phys. 2015 Jun 1; 92(2):220-7. PMID: 25841622; PMCID: PMC4431932 [Available on 06/01/16].
      27. Descovich M, McGuinness C, Kannarunimit D, Chen J, Pinnaduwage D, Pouliot J, Kased N, Gottschalk AR, Yom SS. Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: insights from lung tumor patients treated with robotic radiosurgery. Med Phys. 2015 Mar; 42(3):1280-7. PMID: 25735283.
        View in: PubMed
      28. Axelrod RS, Sherman E, Garden A, Nguyen-Tan PF, Trotti A, Yom SS, Zhang Q. Reply to D. Adkins et al. J Clin Oncol. 2015 Apr 1; 33(10):1224-5. PMID: 25713438.
        View in: PubMed
      29. Al-Shwaiheen FA, Wang SJ, Uzelac A, Yom SS, Ryan WR. The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma. Am J Otolaryngol. 2015 May-Jun; 36(3):415-23. PMID: 25697087.
        View in: PubMed
      30. Yom SS, Diehn M, Raben D. Molecular determinants of radiation response in non-small cell lung cancer. Semin Radiat Oncol. 2015 Apr; 25(2):67-77. PMID: 25771410.
        View in: PubMed
      31. Yom SS. Accelerated repopulation as a cause of radiation treatment failure in non-small cell lung cancer: review of current data and future clinical strategies. Semin Radiat Oncol. 2015 Apr; 25(2):93-9. PMID: 25771413.
        View in: PubMed
      32. Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom SS. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014; 9:269. PMID: 25476839; PMCID: PMC4265326.
      33. Goepfert RP, Yom SS, Ryan WR, Cheung SW. Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma. Laryngoscope. 2015 Apr; 125(4):869-76. PMID: 25388529.
        View in: PubMed
      34. Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015 Feb; 14(1):49-60. PMID: 24325136.
        View in: PubMed
      35. Fogh S, Yom SS. Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician. Semin Oncol. 2014 Dec; 41(6):764-75. PMID: 25499635.
        View in: PubMed
      36. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87. PMID: 25313184.
        View in: PubMed
      37. Thariat J, Yom SS, Sanguineti G, Corry J. Oncology scan--nodal regions, nodal regression, and molecular biomarkers: new thinking in head and neck radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):477-9. PMID: 25304942.
        View in: PubMed
      38. Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50. PMID: 25154822; PMCID: PMC4162493.
      39. Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity. Am J Clin Oncol. 2014 Aug; 37(4):350-5. PMID: 23357970.
        View in: PubMed
      40. Yom SS, Cohen E. The ACR appropriateness criteria® for thyroid carcinoma: searching for consensus in a rapidly evolving area. Oral Oncol. 2014 Jun; 50(6):575-6. PMID: 24824114.
        View in: PubMed
      41. Salama JK, Golden DW, Yom SS, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Smith RV, Worden F, Yeung AR, Beitler JJ. ACR Appropriateness Criteria® thyroid carcinoma. Oral Oncol. 2014 Jun; 50(6):577-86. PMID: 24824115.
        View in: PubMed
      42. Cooper JS, Yom SS. Q&A with Dr Jay S. Cooper about Radiation Therapy Oncology Group 9003. Int J Radiat Oncol Biol Phys. 2014 May 1; 89(1):10-2. PMID: 24725685.
        View in: PubMed
      43. Yu J, Aldabagh B, Wang J, Yom SS, El-Sayed I, Knott D, McGrath MH, Arron S. Multidisciplinary management of advanced basal cell carcinoma: report of four cases. J Drugs Dermatol. 2014 May; 13(5):601-6. PMID: 24809887.
        View in: PubMed
      44. Ouyang D, El-Sayed IH, Yom SS. National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes. Laryngoscope. 2014 Jul; 124(7):1609-14. PMID: 24390781.
        View in: PubMed
      45. George JR, Yom SS, Wang SJ. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis. Laryngoscope. 2014 Jul; 124(7):1603-8. PMID: 24318221.
        View in: PubMed
      46. Chainani-Wu N, Chang C, Gross AJ, Yom SS, Silverman S. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar; 117(3):e261-3. PMID: 24528797.
        View in: PubMed
      47. George JR, Yom SS, Wang SJ. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1118-26. PMID: 24051518.
        View in: PubMed
      48. Ridge JA, Lawson J, Yom SS, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ. American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer. Head Neck. 2014 Jan; 36(1):3-8. PMID: 23696520.
        View in: PubMed
      49. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Aug; 11(8):917-23. PMID: 23946171.
        View in: PubMed
      50. Garg MK, Ridge JA, Yom SS, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ. Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer. Head Neck. 2013 Mar; 35(3):465-6. PMID: 23386559.
        View in: PubMed
      51. Dasgupta T, Haas-Kogan DA, Yang X, Olow A, Yang DX, Gragg A, Orloff LA, Yom SS. Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas. Invest New Drugs. 2013 Oct; 31(5):1136-41. PMID: 23354848.
        View in: PubMed
      52. Yom SS. Oncology scan--head and neck cancers. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):3-5. PMID: 23236994.
        View in: PubMed
      53. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206. PMID: 23289478.
        View in: PubMed
      54. Saba NF, Yom SS, Haigentz M, El-Rayes B. Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors. Chemother Res Pract. 2012; 2012:291421. PMID: 23320170; PMCID: PMC3540736.
      55. Graff P, Kirby N, Weinberg V, Chen J, Yom SS, Lambert L, Pouliot J. The residual setup errors of different IGRT alignment procedures for head and neck IMRT and the resulting dosimetric impact. Int J Radiat Oncol Biol Phys. 2013 May 1; 86(1):170-6. PMID: 23245281.
        View in: PubMed
      56. Kono SA, Haigentz M, Yom SS, Saba N. EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemother Res Pract. 2012; 2012:901320. PMID: 23056941; PMCID: PMC3465896.
      57. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84(5):1198-205. PMID: 22749632; PMCID: PMC3465463.
      58. Yom SS, Chen CP, Jahan TM, Jablons DM. One size does not fit all lung cancer patients. J Thorac Oncol. 2012 May; 7(5):945. PMID: 22722802.
        View in: PubMed
      59. Yeung AR, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yom SS, Beitler JJ. ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck. 2012 May; 34(5):613-6. PMID: 22250010.
        View in: PubMed
      60. Graff P, Hu W, Yom SS, Pouliot J. Does IGRT ensure target dose coverage of head and neck IMRT patients? Radiother Oncol. 2012 Jul; 104(1):83-90. PMID: 22146294.
        View in: PubMed
      61. Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. J Thorac Oncol. 2011 Nov; 6(11):1857-64. PMID: 21964528.
        View in: PubMed
      62. Mannina EM, Pejavar SM, Glastonbury CM, van Zante A, Wang SJ, Yom SS. Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review. Int J Otolaryngol. 2011; 2011:928240. PMID: 21785599; PMCID: PMC3139134.
      63. Yom SS, Garden AS, Staerkel GA, Ginsberg LE, Morrison WH, Sturgis EM, Rosenthal DI, Myers JN, Edeiken-Monroe BS. Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer. AJNR Am J Neuroradiol. 2011 Sep; 32(8):1532-8. PMID: 21757532.
        View in: PubMed
      64. Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ. ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol. 2011 Jul; 47(7):554-9. PMID: 21664857.
        View in: PubMed
      65. McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1292-8. PMID: 21530100.
        View in: PubMed
      66. Chen CP, Wang SJ, van Zante A, Yom SS. Stepwise regional and distant progression of recurrent pleomorphic adenoma. J Otolaryngol Head Neck Surg. 2011 Feb; 40(1):E5-10. PMID: 21303593.
        View in: PubMed
      67. Kangelaris GT, Yom SS, Huang K, Wang SJ. Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma. Int J Otolaryngol. 2010; 2010. PMID: 20862388; PMCID: PMC2939390.
      68. Quon H, Yom SS, Garg MK, Lawson J, McDonald MW, Ridge JA, Saba N, Salama J, Smith R, Yeung AR, Beitler JJ. ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas. Curr Probl Cancer. 2010 May-Jun; 34(3):175-92. PMID: 20541056.
        View in: PubMed
      69. Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom SS. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam. Med Phys. 2010 Apr; 37(4):1737-41. PMID: 20443494.
        View in: PubMed
      70. Tsuji SY, Hwang A, Weinberg V, Yom SS, Quivey JM, Xia P. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 1; 77(3):707-14. PMID: 20231063.
        View in: PubMed
      71. Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963-72. PMID: 20206016.
        View in: PubMed
      72. Sawkey D, Lu M, Morin O, Aubin M, Yom SS, Gottschalk AR, Bani-Hashemi A, Faddegon BA. A diamond target for megavoltage cone-beam CT. Med Phys. 2010 Mar; 37(3):1246-53. PMID: 20384262.
        View in: PubMed
      73. Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1396-403. PMID: 19581056.
        View in: PubMed
      74. Cheung J, Aubry JF, Yom SS, Gottschalk AR, Celi JC, Pouliot J. Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys. 2009 Jun 1; 74(2):583-92. PMID: 19345518.
        View in: PubMed
      75. Hwang AB, Bacharach SL, Yom SS, Weinberg VK, Quivey JM, Franc BL, Xia P. Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys. 2009 Feb 1; 73(2):578-84. PMID: 19084350.
        View in: PubMed
      76. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol. 2009 Jun; 91(3):427-32. PMID: 18937989.
        View in: PubMed
      77. Vitolo V, Millender LE, Quivey JM, Yom SS, Schechter NR, Jereczek-Fossa BA, Milani F, Orecchia R, Xia P. Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy. Radiother Oncol. 2009 Feb; 90(2):213-20. PMID: 18926579.
        View in: PubMed
      78. Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom SS, Phillips TL, Quivey JM. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer. 2008 Aug 1; 113(3):497-507. PMID: 18521908.
        View in: PubMed
      79. Yom SS, Frija EK, Mahajan A, Chang E, Klein K, Shiu A, Ohrt J, Woo S. Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1193-8. PMID: 17967308.
        View in: PubMed
      80. Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007 May 1; 68(1):94-102. PMID: 17321067.
        View in: PubMed
      81. Yom SS, Morrison WH, Ang KK, Rosenthal DI, Perkins GH, Wong PF, Garden AS. Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 1; 66(2):469-76. PMID: 16887292.
        View in: PubMed
      82. Yom SS, Rosenthal DI, El-Naggar AK, Kies MS, Hessel AC. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jun; 101(6):761-8. PMID: 16731397.
        View in: PubMed
      83. Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005 Aug; 28(4):385-92. PMID: 16062081.
        View in: PubMed
      84. Yom SS, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol. 2005 Mar; 18(3):315-9. PMID: 15492756.
        View in: PubMed
      85. Yom SS, Rosenthal DI. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome? Nat Clin Pract Oncol. 2004 Nov; 1(1):14-5. PMID: 16264790.
        View in: PubMed
      86. de Crevoisier R, Ammor A, Court B, Wibault P, Chirat E, Fizazi K, Theodore C, Yom SS, Haie-Meder C. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience. Radiother Oncol. 2004 Aug; 72(2):147-57. PMID: 15376367.
        View in: PubMed
      87. Yom SS, Busch TM, Friedberg JS, Wileyto EP, Smith D, Glatstein E, Hahn SM. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol. 2003 Jul; 78(1):75-81. PMID: 12929752.
        View in: PubMed
      88. Rosenthal DI, Yom SS, Liu L, Machtay M, Algazy K, Weber RS, Weinstein GS, Chalian AA, Mille LK, Rockwell K, Tonda M, Schnipper E, Hershock D. A phase I study of SPI-077 (Stealth liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer. Invest New Drugs. 2002 Aug; 20(3):343-9. PMID: 12201498.
        View in: PubMed
      Sue's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP